Similarly, in this work, no decrease in Cyclin D1 was observed in the tissues with any of the treatments used in this model, this leads to the assumption that the effect observed in the inhibition of tumor development was provided by another route other than the inhibition of Cyclin D1. This evidence concerns the gene CCND1 and neoplasm.